Guotai CSI 1000 Enhanced Strategy ETF(159679.SZ)

Company Encyclopedia
View More
name
Guotai CSI 1000 Enhanced Strategy ETF
159679.SZ
News
View More

Zelgen Biopharma Enters Strategic Partnership with AbbVie For Alveltamig

Suzhou Zelgen Biopharmaceuticals :SAYS IT SIGNS STRATEGIC PARTNERSHIP WITH ABBVIE INC FOR DEVELOPMENT AND COMMERCIALISATION OF ALVELTAMIGSAYS TO RECEIVE $100 MILLION UPFRONT PAYMENT, ADDITIONAL $1.1 BILLION IN MILESTONE PAYMENTS IF ABBVIE EXERCISES LICENSE OPTION

Reuters·
US
ABBV
-0.54%
SH
688266
+0.49%
Reuters·
US
ABBV
-0.54%
SH
688266
+0.49%

Zelgen Biopharma says to receive &100 mln upfront payment, additional $1.1 bln in milestone payments if AbbVie exercises license option

Zelgen Biopharma says to receive &100 mln upfront payment, additional $1.1 bln in milestone payments if AbbVie exercises license option

marketscreener·
SH
688266
+0.49%
marketscreener·
SH
688266
+0.49%
© 2026 Longbridge｜Disclaimer